Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Energy drink innovation declines

This article was originally published in The Tan Sheet

Executive Summary

Market research firm Mintel reports that, after a surge of nearly 400 energy drink and energy shot product introductions in 2008, the rate of launches slowed dramatically, with only 46 new products introduced from January to May 2009. However, sales in the energy beverage segment grew approximately 240 percent between 2004 and 2009, according to the firm's July report on energy beverages. While Mintel projects 2009 energy drink sales will reach $4.6 billion, the recession slowed market growth to less than 10 percent from 2007 to 2008. The firm previously predicted growth would slow as shelves become saturated with energy products (1"The Tan Sheet" Sept. 8, 2008)

You may also be interested in...

Market Experts See Energy Drink Growth Flagging, Dominant Players Reigning

Beverage industry experts foresee the explosive growth rate of the energy drink market falling to earth during the next five years, as products have virtually saturated the market and new customer segments have failed to materialize

Robust Trial Transparency Strategy Boosts Patient Engagement

Most clinical trial sponsors view data disclosure as a mandate, maintaining regulatory compliance as a legal requirement. Study sponsors that realize the potential to repurpose this data, using a patient-first approach, turn transparency into a strategic advantage for engagement and recruitment efforts.

Medtronic’s Perfusion System Recall Is The 5th In 2 Months

The Bio-Console 560 extracorporeal blood pumping console is being recalled over reports it could lose power during bypass surgery, which could lead to organ or neural dysfunction, blood clots, or even death.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts